Form 4: Colgate-Palmolive Executive John W. Kooyman Exercises Stock Options and Sells Shares
SEC Filing
John W. Kooyman, Chief of Staff at Colgate-Palmolive, exercised stock options and sold shares on August 6, 2024.
Summary
- On August 6, 2024, John W. Kooyman, Chief of Staff at Colgate-Palmolive, exercised stock options for 24,781 shares of common stock at a price of $72.29.
- Following the exercise of options, Kooyman sold 24,781 shares of common stock at a weighted average price of $102.8774, with prices ranging from $102.85 to $102.93.
- A portion of the proceeds from the sale was used to cover the exercise price of the options and related tax withholding.
- After these transactions, Kooyman directly owns 3,191 shares and indirectly owns 11,378 shares through the Issuer's 401(k) Plan Trustee.
- Kooyman also continues to hold options to buy 0.0000 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions, with no inherent positive or negative sentiment. It's a factual report of stock option exercise and share sales.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It's common for executives to exercise stock options and sell shares for personal financial management.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives, ensuring compliance with SEC regulations.
- The exercise of stock options and subsequent sale of shares is a common method of compensation for executives in many industries, including consumer goods, where Colgate-Palmolive operates.
- Similar transactions are regularly reported by executives at comparable companies like Procter & Gamble (PG) and Unilever (UL).
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 09/12/2019 | Grant date of the stock options, which became exercisable in one-third increments beginning on the first anniversary. |
| 08/06/2024 | Date of the stock option exercise and share sale. |
| 08/08/2024 | Date of signature by Attorney-in-Fact. |
| 09/12/2027 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.